MHC class II presentation of gp100 epitopes in melanoma cells requires the function of conventional endosomes and is influenced by melanosomes

Journal of Immunology

Volumn 181, Issue 11, 2009, Pages 7843-7852

  Robila, Valentina ^a   Ostankovitch, Marina ^a   Altrich VanLith, Michelle L ^a,e   Theos, Alexander C ^c,f   Drover, Sheila ^b   Marks, Michael S ^c   Restifo, Nicholas ^d   Engelhard, Victor H ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e IBT Laboratories   (United States)

^f GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; EPITOPE; GLYCOPROTEIN GP 100; HLA DR ANTIGEN; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROTEINASE; SMALL INTERFERING RNA;

ARTICLE; CELL DEDIFFERENTIATION; CELL MEMBRANE; CELL MIGRATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DOWN REGULATION; ENDOSOME; HUMAN; HUMAN CELL; INHIBITION KINETICS; LYSOSOME; MELANOMA CELL; MELANOSOME; MUTANT; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; SIGNAL TRANSDUCTION;

EID: 71849085568     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.11.7843     Document Type: Article

References (72)

1. Slingluff, C. L., Jr., K. A. Chianese-Bullock, T. N. Bullock, W. W. Grosh, D. W. Mullins, L. Nichols, W. Olson, G. Petroni, M. Smolkin, and V. H. Engelhard. 2006. Immunity to melanoma antigens: from self-tolerance to immunotherapy. Adv. Immunol. 90: 243-295.
2. Rosenberg, S. A. 1999. A new era for cancer immunotherapy based on the genes that encode cancer antigens. Immunity 10: 281-287.
3. + T cells recognize nonmutated HLA-DR-restricted tyrosinase epitopes. J. Exp. Med. 183: 1965-1971.
4. Kobayashi, H., J. Lu, and E. Celis. 2001. Identification of helper T-cell epitopes that encompass or lie proximal to cytotoxic T-cell epitopes in the gp100 melanoma tumor antigen. Cancer Res. 61: 7577-7584. (Pubitemid 32995051)
5. + T cells. Cancer Res. 60: 4946-4952.
6. Touloukian, C. E., W. W. Leitner, S. L. Topalian, Y. F. Li, P. F. Robbins, S. A. Rosenberg, and N. P. Restifo. 2000. Identification of a MHC class II-restricted human gp100 epitope using DR4-IE transgenic mice. J. Immunol. 164: 3535-3542.
7. Lapointe, R., R. E. Royal, M. E. Reeves, I. Altomare, P. F. Robbins, and P. Hwu. 2001. Retrovirally-transduced human dendritic cells can generate T cells recognizing multiple MHC class I and class II epitopes from the melanoma antigen gp100. J. Immunol. 167: 4758-4764. (Pubitemid 32954358)
8. Robbins, P. F., M. el-Gamil, Y. F. Li, G. Zeng, M. Dudley, and S. A. Rosenberg. 2002. Multiple HLA class II-restricted melanocyte differentiation antigens are recognized by tumor-infiltrating lymphocytes from a patient with melanoma. J. Immunol. 169: 6036-6047.
9. + T cells. Br. J. Cancer 85: 1738-1745.
10. Phan, G. Q., C. E. Touloukian, J. C. Yang, N. P. Restifo, R. M. Sherry, S. L. Topalian, D. J. Schwartzentruber, C. A. Seipp, L. J. Freezer, K. E. Morton, et al. 2003. Immunization of patients with metastatic melanoma using both class I- and class II-restricted peptides from melanoma-associated antigens. J. Immunother. 26: 349-356.
11. Brady, M. S., D. D. Eckels, S. Y. Ree, K. E. Schultheiss, and J. S. Lee. 1996. MHC class II-mediated antigen presentation by melanoma cells. J. Immunother. Emphasis Tumor Immunol. 19: 387-397. (Pubitemid 127495285)
12. Cerundolo, V. 1999. T cells work together to fight cancer. Curr. Biol. 9: R695-R697.
13. + T cells. Proc. Natl. Acad. Sci. USA 97: 400-405.
14. Le Poole, I. C., A. I. Riker, M. E. Quevedo, L. S. Stennett, E. Wang, F. M. Marincola, W. M. Kast, J. K. Robinson, and B. J. Nickollof. 2002. Interferon-γ reduces melanosomal antigen expression and recognition of melanoma cells by cytotoxic T cells. Am. J. Pathol. 160: 521-528.
15. Raposo, G., and M. S. Marks. 2002. The dark side of lysosome-related organelles: specialization of the endocytic pathway for melanosome biogenesis. Traffic 3: 237-248. (Pubitemid 34303256)
16. Raposo, G., D. Tenza, D. M. Murphy, J. F. Berson, and M. S. Marks. 2001. Distinct protein sorting and localization to premelanosomes, melanosomes, and lysosomes in pigmented melanocytic cells. J. Cell Biol. 152: 809-824. (Pubitemid 34280165)
17. Pierre, P., L. K. Denzin, C. Hammond, J. R. Drake, S. Amigorena, P. Cresswell, and I. Mellman. 1996. HLA-DM is localized to conventional and unconventional MHC class II-containing endocytic compartments. Immunity 4: 229-239. (Pubitemid 26132508)
18. Orlow, S. J. 1995. Melanosomes are specialized members of the lysosomal lineage of organelles. J. Invest. Dermatol. 105: 3-7.
19. Hearing, V. J. 1999. Biochemical control of melanogenesis and melanosomal organization. J. Invest. Dermatol. 3: 24-28.
20. Sakai, C., M. Ollmann, T. Kobayashi, Z. Abdel-Malek, J. Muller, W. D. Vieira, G. Imokawa, G. S. Barsh, and V. J. Hearing. 1997. Modulation of murine melanocyte function in vitro by agouti signal protein. EMBO J. 16: 3544-3552. (Pubitemid 27250049)
21. Donatien, P. D., S. L. Diment, R. E. Boissy, and S. J. Orlow. 1996. Melanosomal and lysosomal alterations in murine melanocytes following transfection with the v-rasHa oncogene. Int. J. Cancer 66: 557-563. (Pubitemid 26176773)
22. Li, L., and S. N. Cohen. 1996. Tsg101: a novel tumor susceptibility gene isolated by controlled homozygous functional knockout of allelic loci in mammalian cells. Cell 3: 319-329. (Pubitemid 26160704)
23. Bouchard, B., B. B. Fuller, S. Vijayasaradhi, and A. N. Houghton. 1989. Induction of pigmentation in mouse fibroblasts by expression of human tyrosinase cDNA. J. Exp. Med. 169: 2029-2042. (Pubitemid 19162964)
24. Berson, J. F., D. C. Harper, D. Tenza, G. Raposo, and M. S. Marks. 2001. Pmel17 initiates premelanosome morphogenesis within multivesicular bodies. Mol. Biol. Cell. 12: 3451-3464.
25. Raposo, G., and M. S. Marks. 2007. Melanosomes-dark organelles enlighten endosomal membrane transport. Nat. Rev. Mol. Cell Biol. 8: 786-797. (Pubitemid 47462136)
26. Theos, A. C., S. T. Truschel, G. Raposo, and M. S. Marks. 2005. The Silver locus product Pmel17/gp100/Silv/ME20: controversial in name and in function. Pigm. Cell Res. 18: 322-336.
27. Cormier, J. N., A. Abati, P. Fetsch, Y. M. Hijazi, S. A. Rosenberg, F. M. Marincola, and S. L. Topalian. 1998. Comparative analysis of the in vivo expression of tyrosinase, MART-1/Melan-A, and gp100 in metastatic melanoma lesions: implications for immunotherapy. J. Immunother. 21: 27-31.
28. Lapointe, R., J. Thibodeau, and P. Hwu. 2004. CD40-stimulated B lymphocytes pulsed with tumor antigens are effective antigen-presenting cells that can generate specific T cells. Cancer Res. 64: 4056-4057. (Pubitemid 36667155)
29. Berson, J. F., A. C. Theos, D. C. Harper, D. Tenza, G. Raposo, and M. S. Marks. 2003. Proprotein convertase cleavage liberates a fibrillogenic fragment of a resident glycoprotein to initiate melanosome biogenesis. J. Cell Biol. 161: 521-533.
30. Chiamenti, A. M., F. Vella, F. Bonetti, M. Pea, S. Ferrari, G. Martignoni, A. Benedetti, and H. Suzuki. 1996. Anti-melanoma monoclonal antibody HMB-45 on enhanced chemiluminescence-western blotting recognizes a 30-35 kDa melanosome-associated sialated glycoprotein. Melonoma Res. 6: 291-298.
31. Theos, A. C., S. T. Truschel, D. Tenza, I. Hurbain, D. C. Harper, J. F. Berson, P. C. Thomas, G. Raposo, and M. S. Marks. 2006. A lumenal domain-dependent pathway for sorting to intralumenal vesicles of multivesicular endosomes involved in organelle morphogenesis. Dev. Cell. 10: 343-354.
32. Hoashi, T., J. Muller, W. D. Vieira, F. Rouzaud, K. Kikuchi, K. Tamaki, and V. J. Hearing. 2006. The repeat domain of the melanosomal matrix protein PMEL17/GP100 is required for the formation of organellar fibers. J. Biol. Chem. 281: 21198-21208. (Pubitemid 44115459)
33. Valencia, J. C., H. Watabe, A. Chi, F. Rouzaud, K. G. Chen, W. D. Vieira, K. Takahashi, Y. Yamaguchi, W. Berens, K. Nagashima, et al. 2006. Sorting of Pmel17 to melanosomes through the plasma membrane by AP1 and AP2: evidence for the polarized nature of melanocytes. J. Cell Sci. 119: 1080-1091.
34. Theos, A. C., J. F. Berson, S. C. Theos, K. E. Herman, D. C. Harper, D. Tenza, E. V. Sviderskaya, M. L. Lamoreux, D. C. Bennett, G. Raposo, and M. S. Marks. 2006. Dual loss of ER export and endocytic signals with altered melanosome morphology in the silver mutation of Pmel17. Mol. Biol. Cell. 17: 3598-3612.
35. Harper, D. C., A. C. Theos, K. E. Herman, D. Tenza, G. Raposo, and M. S. Marks. 2008. Premelanosome amyloid-like fibrils are composed of only Golgi-processed forms of Pmel17 that have been proteolytically processed in endosomes. J. Biol. Chem. 283: 2307-2322.
36. Bryant, P., and H. Ploegh. 2004. Class II MHC peptide loading by the professionals. Curr. Opin. Immunol. 16: 96-102. (Pubitemid 38198123)
37. Zhong, G., P. Romagnoli, and R. N. Germain. 1997. Related leucine-based cytoplasmic targeting signals in invariant chain and major histocompatibility complex class II molecules control endocytic presentation of distinct determinants in a single protein. J. Exp. Med. 185: 429-438. (Pubitemid 27078361)
38. Sloan, V. S., P. Cameron, G. Porter, M. Gammon, M. Amaya, E. Mellins, and D. M. Zaller. 1995. Mediation by HLA-DM of dissociation of peptides from HLA-DR. Nature 375: 802-806.
39. Pinet, V., M. Vergelli, R. Martin, O. Bakke, and E. O. Long. 1995. Antigen presentation mediated by recycling of surface HLA-DR molecules. Nature 375: 603-606.
40. Lindner, R., and E. R. Unanue. 1996. Distinct antigen MHC class II complexes generated by separate processing pathways. EMBO J. 15: 6910- (Pubitemid 27023262)
41. Griffin, J. P., R. Chu, and C. V. Harding. 1997. Early endosomes and a late endocytic compartment generate different peptide-class II MHC complexes via distinct processing mechanisms. J. Immunol. 158: 1523-1532.
42. Sinnathamby, G., and L. C. Eisenlohr. 2003. Presentation by recycling MHC class II molecules of an influenza hemagglutinin-derived epitope that is revealed in the early endosome by acidification. J. Immunol. 170: 3504-3513. (Pubitemid 36359216)
43. Slingluff, C. L., T. A. Colella, L. Thompson, D. D. Graham, J. C. A. Skipper, J. A. Caldwell, L. Brinkerhoff, D. J. Kittlesen, D. H. Deacon, C. Oei, et al. 2000. Melanomas with concordant loss of multiple melanocytic differentiation proteins: immune escape that may be overcome by targeting unique or undefined antigens. Cancer Immunol. Immunother. 48: 661-672.
44. Ostankovitch, M., V. Robila, and V. H. Engelhard. 2005. Regulated folding of tyrosinase in the endoplasmic reticulum demonstrates that misfolded full-length proteins are efficient substrates for class I processing and presentation. J. Immunol. 174: 2544-2551. (Pubitemid 40279667)
45. Lampson, L. A., and R. Levy. 1980. Two populations of Ia-like molecules on a human B cell line. J. Immunol. 125: 293-299.
46. Drover, S., W. H. Marshall, W. W. Kwok, G. T. Nepom, and R. W. Karr. 1994. Amino acids in the peptide-binding groove influence an antibody-defined, disease-associated HLA-DR epitope. Scand. J. Immunol. 39: 539-550. (Pubitemid 24217146)
47. + T cells is independent of distinct human leucocyte antigen-bound peptides. Clin. Exp. Allergy 32: 1635-1643.
48. Lee, Z. H., L. Hou, G. Moellmann, E. Kuklinska, K. Antol, M. Fraser, R. Halaban, and B. S. Kwon. 1996. Characterization and subcellular localization of human Pmel 17/silver, a 110-kDa (pre)melanosomal membrane protein associated with 5,6,-dihydroxyindole-2-carboxylic acid (DHICA) converting activity. J. Invest. Dermatol. 106: 605-610.
49. Lich, J. D., J. F. Elliott, and J. S. Blum. 2000. Cytoplasmic processing is a prerequisite for presentation of an endogenous antigen by major histocompatibility complex class II proteins. J. Exp. Med. 191: 1513-1524.
50. Mukherjee, P., A. Dani, S. Bhatia, N. Singh, A. Y. Rudensky, A. George, V. Bal, S. Mayor, and S. Rath. 2001. Efficient presentation of both cytosolic and endogenous transmembrane protein antigens on MHC class II is dependent on cytoplasmic proteolysis. J. Immunol. 167: 2632-2641. (Pubitemid 32768892)
51. Tewari, M., G. Sinnathamby, D. Rajagopal, and L. Eisenlohr. 2005. A cytosolic pathway for MHC class II-restricted antigen processing that is proteasome and TAP dependent. Nat. Immunol. 6: 287-294. (Pubitemid 41724766)
52. Mosse, C. A., L. Meadows, C. J. Luckey, D. J. Kittlesen, E. L. Huczko, C. L. Slingluff, Jr., J. Shabanowitz, D. F. Hunt, and V. H. Engelhard. 1998. The class I antigen processing pathway for the membrane protein tyrosinase involves translation in the endoplasmic reticulum and processing in the cytosol. J. Exp. Med. 187: 37-48.
53. Luckey, C. J., G. M. King, J. A. Marto, S. Venketeswaran, B. F. Maier, V. L. Crotzer, T. A. Colella, J. Shabanowitz, D. F. Hunt, and V. H. Engelhard. 1998. Proteasomes can either generate or destroy MHC class I epitopes: evidence for nonproteasomal epitope generation in the cytosol. J. Immunol. 161: 112-121.
54. Pinet, V. M., and E. O. Long. 1998. Peptide loading onto recycling HLA-DR molecules occurs in early endosomes. Eur. J. Immunol. 28: 799-804.
55. + T cells during pulmonary influenza virus infection. J. Immunol. 173: 1209-1218.
56. Fernandes, D. M., L. Vidard, and K. L. Rock. 2000. Characterization of MHC class II-presented peptides generated from an antigen targeted to different endocytic compartments. Eur. J. Immunol. 30: 2333-2343.
57. Yasumoto, K., H. Watabe, J. C. Valencia, T. Kushimoto, T. Kobayashi, E. Appella, and V. J. Hearing. 2004. Epitope mapping of the melanosomal matrix protein gp100 (PMEL17): rapid processing in the endoplasmic reticulum and glycosylation in the early Golgi compartment. J. Biol. Chem. 279: 28330-28338. (Pubitemid 38900112)
58. Dugast, M., H. Toussaint, C. Dousset, and P. Benaroch. 2005. AP2 clathrin adaptor complex, but not AP1, controls the access of the major histocompatibility complex (MHC) class II to endosomes. J. Biol. Chem. 280: 19656-19664. (Pubitemid 41379489)
59. McCormick, P. J., J. A. Martina, and J. S. Bonifacino. 2005. Involvement of clathrin and AP-2 in the trafficking of MHC class II molecules to antigen-processing compartments. Proc. Natl. Acad. Sci. USA 102: 7910-7915.
60. Janvier, K., and J. S. Bonifacino. 2005. Role of the endocytic machinery in the sorting of lysosome-associated membrane proteins. Mol. Biol. Cell. 16: 4231-4242. (Pubitemid 41262892)
61. Doray, B., I. Lee, J. Knisely, G. Bu, and S. Kornfeld. 2007. The γ/σ1 and γ/σ2 hemicomplexes of clathrin adaptors AP-1 and AP-2 harbor the dileucine recognition site. Mol. Biol. Cell. 18: 1887-1896. (Pubitemid 46717568)
62. Bonifaz, L. C., S. Arzate, and J. Moreno. 1999. Endogenous and exogenous forms of the same antigen are processed from different pools to bind MHC class II molecules in endocytic compartments. Eur. J. Immunol. 29: 119-131.
63. Zhou, D., P. Li, Y. Lin, J. M. Lott, A. D. Hislop, D. H. Canaday, R. R. Brutkiewicz, and J. S. Blum. 2005. Lamp-2a facilitates MHC class II presentation of cytoplasmic antigens. Immunity 22: 571-581. (Pubitemid 40719193)
64. Jaraquemada, D., M. Marti, and E. O. Long. 1990. An endogenous processing pathway in vaccinia virus-infected cells for presentation of cytoplasmic antigens to class II-restricted T cells. J. Exp. Med. 172: 947-954. (Pubitemid 20301241)
65. Malnati, M. S., S. Ceman, M. Weston, R. DeMars, and E. O. Long. 1993. Presentation of cytosolic antigen by HLA-DR requires a function encoded in the class II region of the MHC. J. Immunol. 151: 6751-6756.
66. Lepage, S., and R. Lapointe. 2006. Melanosomal targeting sequences from gp100 are essential for MHC class II-restricted endogenous epitope presentation and mobilization to endosomal compartments. Cancer Res. 66: 2423-2432. (Pubitemid 43294958)
67. Bonifacino, J. S., and L. M. Traub. 2003. Signals for sorting of transmembrane proteins to endosomes and lysosomes. Annu. Rev. Bioch. 72: 395-447.
68. Theos, A. C., D. Tenza, J. A. Martina, I. Hurbain, A. A. Peden, E. V. Sviderskaya, A. Stewart, M. S. Robinson, D. C. Bennett, D. F. Cutler, et al. 2005. Functions of adaptor protein (AP)-3 and AP-1 in tyrosinase sorting from endosomes to melanosomes. Mol. Biol. Cell. 16: 5356-5372.
69. Di Pietro, S. M., J. M. Falcon-Perez, D. Tenza, S. R. Setty, M. S. Marks, G. Raposo, and E. C. Dell'Angelica. 2006. BLOC-1 interacts with BLOC-2 and the AP-3 complex to facilitate protein trafficking on endosomes. Mol. Biol. Cell 17: 4027-4038.
70. Wasmeier, C., M. Romao, L. Plowright, D. C. Bennett, G. Raposo, and M. C. Seabra. 2006. Rab38 and Rab32 control post-Golgi trafficking of melanogenic enzymes. J. Cell Biol. 175: 271-281. (Pubitemid 44631421)
71. Setty, S. R., D. Tenza, S. T. Truschel, E. Chou, E. V. Sviderskaya, A. C. Theos, M. L. Lamoreux, S. M. Di Pietro, M. Starcevic, D. C. Bennett, et al. 2007. BLOC-1 is required for cargo-specific sorting from vacuolar early endosomes toward lysosome-related organelles. Mol. Biol. Cell. 18: 768-780.
72. Urabe, K., P. Aroca, and V. J. Hearing. 1993. From gene to protein: determination of melanin synthesis. Pigm. Cell Res. 6: 186-192.